Podcast

Antje Bischof on Spinal Cord Atrophy in Relapsing MS

05/08/2019

 

Antje Bischof, from the University of California, San Fransisco, talks about her research "Accelerated Cord Atrophy Precedes Conversion to Secondary Progressive Disease in Relapsing Multiple Sclerosis," which she presented at ACTRIMS Forum 2019.

Antje Bischof is a postdoctoral scholar in neurology at the University of California, San Francisco.

To read her research from ACTRIMS Forum 2019, click here.

For more Conference Insider coverage of ACTRIMS 2019, click here.

 

Related Content

Inflammatory Bowel Disease
Inflammatory Bowel Disease
David Hudesman, MD, on Shared Decision-Making in IBD Therapy: Ensuring Patients Don't Fail
10/31/2018
Dr David Hudesman from NYU Langone discusses why some patients with IBD fail their medication, how gastroenterologists can approach this, and more.
10/31/2018
Psoriatic Arthritis
Psoriatic Arthritis
Neal Birnbaum, MD, on Addressing Progression in Psoriatic Arthritis
12/16/2020
He talks about the challenges of treating progressive psoriatic arthritis, why certain patients progress to more severe disease, and how to change medication when needed.
12/16/2020
Inflammatory Bowel Disease
Inflammatory Bowel Disease
Christina Ha, MD, on Treating IBD in the Elderly
11/27/2019
Dr Ha, from Cedars-Sinai Medical Center, discusses the management of inflammatory bowel disease in the elderly, the potential for undertreatment, balancing medication interactions, and more.
11/27/2019
Lupus Nephritis
Lupus Nephritis
Saira Sheikh, MD, on More Diverse Clinical Trials Can Lead to Improved Outcomes in Lupus
12/10/2018
Dr Saira Sheikh from University of North Carolina at Chapel Hill discusses the lack of diversity in Lupus clinical trials, the new ACR partnership aimed at increasing access to trials for minorities, the...
12/10/2018
Cardiometabolic Risk
Cardiometabolic Risk
Robert Giugliano, MD, on the Results From IMPROVE-IT
10/22/2019
In this podcast, Robert P. Giugliano, MD, discusses the safety and efficacy findings from IMPROVE-IT, the practical implications for ezetimibe, and more.
10/22/2019